Fibrosis News and Research

RSS

Fibrosis is the growth of fibrous tissue.

UVA research could help identify COVID-19 survivors at risk for long-haul lung problems

UVA Health researchers have discovered a potential way to predict which patients with severe COVID-19 are likely to recover well and which are likely to suffer "long-haul" lung problems.

15 Mar 2024

New custom-designed proteins can efficiently reach intramembrane targets

Hitting targets embedded within the cell membrane has long been difficult for drug developers due to the membrane's challenging biochemical properties. Now, Scripps Research chemists have demonstrated new custom-designed proteins that can efficiently reach these "intramembrane" targets.

13 Mar 2024

Maternal obesity linked to liver cancer risk in offspring

Obesity, which could reach 50% of the population in certain developed countries by 2030, is a major public health concern.

12 Mar 2024

Recent advances in injectable hydrogel-mediated myocardial infarction therapy

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Myocardial infarction (MI) triggers adverse remodeling mechanisms, thus leading to heart failure.

11 Mar 2024

Microplastics and nanoplastics could be harming your heart health

Whether micro- and nano-plastics (MNPs) are detectable in atherosclerotic plaques.

11 Mar 2024

New research identifies potential drug target to prevent kidney failure

A new study found that retinoic acid receptors (RARa) in the proximal tubules of the kidney play a crucial role in limiting the damaging effects of kidney injury that often lead to kidney failure.

9 Mar 2024

Food insecurity fuels fatty liver disease in Latinx kids

For Latinx kids, unreliable access to food at age 4 raises the odds of having fatty liver disease later in childhood by nearly four times, a new UC San Francisco-led study found.

9 Mar 2024

Common age-associated changes in the blood found to be a risk factor for acute kidney injury

A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury (AKI), which occurs in more than 1 in 5 hospitalized adults worldwide.

7 Mar 2024

Researchers take important step toward genetic therapy for hereditary conditions

Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.

5 Mar 2024

UCSF scientists discover less invasive prenatal treatment for Angelman syndrome

In a discovery that opens the door to a less invasive way of treating some serious disorders before birth, UC San Francisco scientists have found that delivering medicine through amniotic fluid is as effective as delivering it to the fetal brain via cerebrospinal fluid.

4 Mar 2024

Penn engineers develop targeted lung delivery system using lipid nanoparticles

Penn Engineers have developed a new means of targeting the lungs with lipid nanoparticles (LNPs), the miniscule capsules used by the Moderna and Pfizer-BioNTech COVID-19 vaccines to deliver mRNA, opening the door to novel treatments for pulmonary diseases like cystic fibrosis.

1 Mar 2024

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Amyotrophic Lateral Sclerosis (ALS) is a fatal type of motor neuron disease characterized by progressive degeneration of nerve cells in the spinal cord and brain, resulting in muscle weakness and paralysis that can include the inability to walk and speak, or even swallow and breathe.

27 Feb 2024

Breakthrough discovery offers hope for reducing infections in cystic fibrosis patients

Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus

Researchers investigated the link between non-alcoholic fatty liver disease in individuals with type 2 diabetes mellitus (T2DM) and all-cause death and cardiovascular disease.

16 Feb 2024

Fibrosis News and Research

Further Reading

UVA research could help identify COVID-19 survivors at risk for long-haul lung problems

New custom-designed proteins can efficiently reach intramembrane targets

Maternal obesity linked to liver cancer risk in offspring

Recent advances in injectable hydrogel-mediated myocardial infarction therapy

Microplastics and nanoplastics could be harming your heart health

New research identifies potential drug target to prevent kidney failure

Food insecurity fuels fatty liver disease in Latinx kids

Common age-associated changes in the blood found to be a risk factor for acute kidney injury

Researchers take important step toward genetic therapy for hereditary conditions

UCSF scientists discover less invasive prenatal treatment for Angelman syndrome

Penn engineers develop targeted lung delivery system using lipid nanoparticles

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Breakthrough discovery offers hope for reducing infections in cystic fibrosis patients

Cedars-Sinai researchers discover why some injured kidneys heal while others develop scarring

Targeting the Hippo signaling pathway to treat systemic sclerosis

Mitochondrial activation enhances cardiac regeneration therapy

Breakthrough gene therapy method utilizes bird retrotransposon for safe gene insertion

Innovative computer model of the lung enables detailed simulation of radiation effects

New standards for evaluating aging biomarkers unveiled

Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News